Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
12%
OVERLAP
BY WEIGHT
3
# OF OVERLAPPING
HOLDINGS
THNR
19
HOLDINGS
17%
ALSO IN IDNA
IDNA
44
HOLDINGS
8%
ALSO IN THNR
SECTOR DRIFT (THNR minus IDNA)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in THNR |
Weight in IDNA |
Overlap | |
|---|---|---|---|---|
 |
REGENERON PHARMACEUTICALS | 6.7% | 4.5% | 4.5% |
|
MERCK & CO. INC. | 4.6% | 3.9% | 3.9% |
 |
ROCHE HOLDING LTD | 4.7% | 3.8% | 3.8% |
THNR Overweight Relative to IDNA
 |
NOVO-NORDISK A/S-SPONS ADR | 12.9% |
|
ELI LILLY & CO | 12.1% |
|
AMGEN INC | 6.5% |
 |
CHUGAI PHARMACEUTICAL CO LTD | 6.2% |
|
HIMS & HERS HEALTH, INC. CLASS A | 5.7% |
|
ABBVIE INC | 5.0% |
|
SHIONOGI & CO LTD | 4.9% |
 |
INNOVENT BIOLOGICS, INC. | 4.8% |
|
PFIZER INC | 4.8% |
 |
ASTRAZENECA PLC-SPONS ADR | 4.6% |
THNR Underweight Relative to IDNA
|
GENMAB A/S | -5.1% |
|
INCYTE CORP | -4.7% |
|
ARCELLX, INC. | -4.6% |
|
REVOLUTION MEDICINES, INC. | -4.2% |
|
ASTRAZENECA PLC | -3.9% |
|
TAKEDA PHARMACEUTICAL CO LTD | -3.9% |
|
GSK PLC | -3.8% |
 |
SANOFI-AVENTIS | -3.6% |
|
EXELIXIS INC | -3.5% |
 |
BIONTECH SE SPONSORED ADR | -3.5% |